-+ 0.00%
-+ 0.00%
-+ 0.00%

QUINCE THERAPEUTICS - LAM-001 GENERALLY WELL TOLERATED IN PHASE 2A STUDY

Reuters·05/18/2026 13:26:19

Please log in to view news